science π¬ Indian scientists create smart cancer drug candidate
Indian scientists have developed a new smart cancer drug candidate designed to activate specifically inside tumour cells. This research was led by Dr Asis Bala of IASST and Dr K.P. Bhabak of IIT Guwahati. The candidate, RK-251, showed strong activity against aggressive triple-negative breast cancer cells in preclinical tests. This targeted approach aims to reduce side effects common in conventional cancer treatments by using ROS as a trigger. Further lab studies and clinical trials are required before RK-251 can be used in patients. π¬